What is the trend in tetanus (lockjaw) incidence over the last 50 years?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tetanus Incidence Decline Over the Last 50 Years

Tetanus incidence in the United States has declined by over 98% from 1947 to 2016, dropping from 560 cases (0.39 per 100,000 population) in 1947 to approximately 30 cases annually (0.01 per 100,000 population) by 2016. 1

Historical Trajectory

Early Reporting Period (1947-1987)

  • 1947: 560 reported cases when national reporting began (0.39 per 100,000 population) 1
  • 1987: Record low of 48 reported cases at that time 1
  • This represents a 91% decline over the first 40 years of surveillance 1

Recent Decades (1986-2016)

  • 1986-1989: Cases remained relatively stable at 48-64 cases annually 1
  • 1995-1997: Average of 41 cases per year (0.15 per 1,000 population) 2
  • 1998-2000: Average of 43 cases annually (0.16 cases per million population) 3
  • 2001-2016: 459 non-neonatal cases total (approximately 29 cases per year) with incidence of 0.01 per 100,000 population 1

Key Drivers of Decline

The dramatic reduction resulted from multiple factors 1:

  • Widespread tetanus toxoid vaccination introduced in the mid-1940s, with near-universal childhood vaccination (97% of school-entry children receiving ≥3 doses of DTP) 1
  • Improved wound management including routine tetanus prophylaxis in emergency departments 1
  • Improved hygiene during childbirth and increased maternal immunity 1
  • Expanded urbanization 1

Neonatal Tetanus Elimination

  • 1972-1984: 29 cases of neonatal tetanus reported 1
  • 1985-1989: Zero cases of neonatal tetanus reported 1
  • 2001-2016: Only 3 neonatal tetanus cases reported over 16 years 1

Mortality Trends

The case-fatality ratio has also declined significantly 1:

  • 1987-1988: 21% case-fatality rate 1
  • 1998-2000: 18% case-fatality rate 3
  • 2001-2016: 8.0% case-fatality rate 1

Global Context

Worldwide data from 1990-2019 shows continued decline in tetanus incidence and death rates globally, with the most dramatic reductions occurring in high sociodemographic index countries 4. The disease burden decreased significantly across all regions during this 30-year period 4.

Current Epidemiologic Pattern

Despite the dramatic decline, tetanus persists primarily among 1:

  • Older adults: 68% of cases occur in persons ≥50 years of age, with median age of 44 years 1
  • Unvaccinated or inadequately vaccinated individuals: Disease occurs almost exclusively in this population 1
  • Males: 60% of cases occur in males 1

The low prevalence of protective antibodies in older adults (only 45% of men and 21% of women aged ≥70 years have protective levels) explains the continued occurrence in this age group 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tetanus surveillance--United States, 1995-1997.

MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries, 1998

Research

Tetanus surveillance--United States, 1998--2000.

Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002), 2003

Research

Global epidemiology and burden of tetanus from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.